NKA Bio
PrivateLast Round
Accelerator
Mar 11, 2024
Total Funding Raised
$120,000
Momentum Score
25 /100
Company Overview
NKA Bio is a biotechnology startup that is developing biopharmaceuticals to improve critical care, particularly for treating shock from traumatic injuries. The company's main product, NKA01, is an injectable antibody drug designed to be administered by first responders at the point of injury. This treatment aims to stabilize patients and "press pause on death," buying crucial hours for transport to a trauma center for surgery and advanced care. The company's technology is based on the research of Dr. Donald S. Gann, a pioneer in trauma care and the first Director of Emergency Medicine at Johns Hopkins. NKA Bio's pipeline also includes programs for septic shock, acute lung injury, and heart attack resuscitation. The company was founded in 2023 and is based in Baltimore, Maryland.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical AI
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NKA Bio Comps
Public and private peers based on sector, stage, and business model.
NKA Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Mar 11, 2024 | ||||
| Accelerator | Sep 5, 2023 |
Key People
Founding team and executive leadership
NKA Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Techstars | Accelerator |
| The Innovation Space | Accelerator |
NKA Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NKA Bio's valuation, stock price, and market status.
